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ABSTRACT 
Medical non-adherence increasingly is recognized as a 
major medical health problem. Approximately 50% of 
patients do not take their medications as prescribed 
and such poor adherence has been shown to result in 
complications, death, and increased health care costs 
[1, 2, 5].   
This problem becomes even more significant for 
patients with chronic illness and those who need to 
take medications lifetime, like transplant patients.  
Studies show that one half of rejection episodes and 
15% of graft losses happen due to immunosuppression 
medications non-adherence [3, 4]. 
This article explores factors that have an impact on 
non-compliant behavior among transplant patients: 
patient factors, illness factor, therapeutic regimen 
factors [5, 6, 7].  Using user-centered design thinking 
approach based on these analyses a set of the 
hypothesisis defined and discussed strategies to 
enhance adherence by using mobile technology and 
gamification techniques. 
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INTRODUCTION 
According to a 2003 report published by the WHO, 
adherence rates in developed countries only about 
50% [9]. 
Adherence is a key factor associated with the 
effectiveness of treatment and is particularly critical 
for medications prescribed for chronic conditions. Of 
all medication-related hospitalizations that occur in 
the United States, between 30% and 60% are the 
result [10] of poor medication adherence. 
Studies show that 20% to 80% of patients make errors 
in taking medication and that 20% to 60% stop taking 
medications before being instructed to do so [11, 12]. 
With older populations, the literature concerning 
adherence reports that compliance rates range roughly 
from 38% to 57%, with an average rate of less than 
45% [13, 14]. 
The most consistently reported factors impacting 
adherence are low literacy, lack of health insurance 
coverage, poor social support and family instability 
[15]. It has been reported that one-half of adults lack 
the skills to complete tasks related to following 
medication-label directions, comprehending nutrition 
labels, describing symptoms, or using a map to locate 
health facilities [15].   
Decreased health literacy has been reported with 
increasing age, such that adults aged 60 years may not 
understand basic materials such as medication labels.  
Patient beliefs about the diagnosis and medication 
benefits also have been shown to affect the adherence 
rate regardless of whether the patient can afford the 
medication. This means that patients may have a low 
perceived need for the medication and more concerns 
about side effects, thus possibly choosing to forgo the 
cost of the medication based on their beliefs [16]. 
The following steps have been shown to increase 
adherence [15]: verifying the patient’s understanding 
of the disease and its treatment and providing 
education where gaps in understanding exist; 
correlating medication-taking with other daily 
routines; using medication organizers or charts; 
reducing the pill burden, if possible; providing care 
support. 
In this research the human-centered design process 
was used to find the innovative, impactful solution 
that would help to increase adherence.  
Research methodology involved a user-centred design 
approach incorporating strategies of human factors 
engineering, cognitive behavior science and elements 
of social marketing, followed by an iterative prototype 
test phase within the target population. This research 
resulted in a concept of a mobile application that will 
create a positive reinforcement through the 
gamification experience.  The concept applies to a 
wide range of patients but discussed in particular for 
transplant patients.   
 
METHOD 
User-Centered Design (UCD) is a multidisciplinary 
design approach based on the active involvement of 
users to improve the understanding of user and task 
requirements, and the iteration of design and 
evaluation. It is widely considered the key to product 
usefulness and usability - an effective approach to 
overcoming the limitations of traditional system-
centered design.  
The human-centered design process has three phases 
— the Inspiration phase, the Ideation phase, and the 
Implementation phase. By keeping people in the heart 
of the design process we are making sure that the final 
solution will be tailored to their needs. 
In the Inspiration phase we learn directly from the 
people were are designing for and immersing 
ourselves in their lives and come to deeply understand 
their needs. In the Ideation phase we are making sense 
of what we learned, identifying opportunities for 
design, and prototype the solutions. And in the 
Implementation phase are bringing our solution to life, 
and eventually, to people. 
In this study we focused on defining the solution to 
medical non adherence for patients who had transplant 
surgery on liver, kidney, heart, lung, intestine or 
pancreas.   
For the research we selected transplant patients who 
had surgery within the last year and more than three 
years before. This allowed us to see more details on 
how transplant patient’s life change with time and also 
it allowed us to explore either extreme of the 
spectrum. An idea that suits an extreme user will 
nearly certainly work for the majority too. More 
importantly, talking to extremes can spark creativity 
by exposing you to use cases that you’d never have 
imagined on your own. 
Multiple studies were conducted - interviews, 
observations, diary studies, co-design sessions, 
surveys. The goal was to step into transplant patients’ 
shoes, to understand their lives and solve problems 
from their perspectives. 
 
RESULTS 
Insights that were got from the users during the 
research phase and understanding of medical non-
adherence due to previous researches [17] drove us to 
the several hypotheses with the focus on the mobile 
experience.  
1.1 Personalization based on the patients’ needs 
Standard pills reminders products are extremely hard 
to use - they are generic and try to satisfy patients with 
the different condition by building monstrous 
interfaces. So the solution should be only about 
transplant patients and their special treatments. 
 
1.2 Smart guidance to the anti-rejection medicine 
During the first several months, patients feel 
overwhelmed with information; they need to learn 
about their new organ, how to take care of it, and how 
to avoid rejection and infection. So the solution should 
be a smart guide to the anti-rejection medicine.  
We should be focusing on some of the most important 
medications and timing them appropriately — so users 
don’t have to. Together with that user should have 
total control over the timing of the medication 
notifications.  
 
1.3 Positive reinforcement for medication adherence 
The patient’s life is changing dramatically for the 
better within several weeks after the surgery and they 
often treat the day of the surgery as their second 
birthday. So visual language and style of the mobile 
solution should emphasize the new, energetic patient’s 
life, far away from a hospital.  
Patients rarely admit that they are missing 
medications. In fact, sometimes they even hardly 
notice that they miss their anti-rejection medicine - 
they don’t feel the immediate impact but it can be 
very dangerous if users miss their drugs often. 
Guilt, shame, or a sense of failure doesn’t help here. 
So, instead of being strict and demanding the solution 
should be a friend. It shouldn’t stress them or punish 
them. It’s soft and gentle reminder. 
 
1.4 Engaging into the treatment through gamification 
techniques 
The reward system was created and tested with the 
target group of transplant patients [18].   
By introducing to the patients “7 Day Challenge” 
where they needed to take their medications for 7 days 
in a row without missing a dose we aimed to shift the 
focus from “You have to take medications” to “I want 
to take my medications”.  After completing the 
challenge users are involved into the game that 
encourages them to earn rewards towards eventually 
gather them all.  
 
Table 1. Awards system for the patient’s activities 
The developed gamification system for transplant 
patients was tested on the group of potential users and 
through iterations we got to the understanding of the 
game level system that will be impactful to the 
medication adherence (see Table 1). 
 
DISCUSSION AND CONCLUSIONS 
All the hypothesis were combined to design a final 
mobile solution that was tested in the study [19] where 
sixty-seven renal transplant recipients were 
prospectively enrolled and randomized into 2 groups: 
18 app users and 49 nonusers.   
The variability in tacrolimus levels was calculated 
using the coefficient of variability (CV): CV = 
(standard deviation/mean tacrolimus) x 100. CV has 
been shown to be a critical indicator of chronic 
rejection determined during protocol biopsies of renal 
allografts.   
In the patient cohort, CV was significantly lower in 
app users compared to nonusers at 1 month (27.7 vs 
37.0, respectively, P=0.014). CV at 1 month was a 
significant predictor of app utilization (odds ratio 
0.916; 95% confidence interval 0.858-0.977; P=0.007) 
[20].  
The CV reduction in app users at 1 month has shown a 
potential of such mobile solution to improve 
medication adherence in the early postoperative 
period when patients may be at highest risk for 
medication non adherence. 
The rate of missed medications was also lower by 
28% among app users who completed at least three “7 
Day Challenges” and we found the direct correlation 
between missed doses and level achieved in the game 
system. This shows a positive influence of the game 
element of the proposed solution to the medical 
adherence of the transplant patients. 
Further investigation can explore what elements of the 
game design may be improved to engage more users 
and also establish more factors that show correlation 
with patient behavior and health.   
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